Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Phillip Scheinberg Kelsey Loeliger |
| Publication date | November 1, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |